BioCentury
ARTICLE | Clinical News

AF-130: Phase I started

January 18, 2016 8:00 AM UTC

Afferent began a 2-part, double-blind, placebo-controlled, U.K. Phase I trial to evaluate oral AF-130 in about 109 healthy volunteers. The first part will evaluate single ascending doses of AF-130 in ...